Fact CheckerSign in

NCT06503874Completed

Improving Attention in Individuals With Long COVID-19

Intensive Attention Training to Treat Brain Fog in Individuals With Long-Covid

Source: ClinicalTrials.gov · Last updated 2 Apr 2026

Brief summary (registry, in English)

This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.

Status (registry)
Completed
Study type
Interventional
Enrollment
58 (actual)
First submitted
9 Jul 2024
Start date
22 Mar 2024
Primary completion date
13 Mar 2026
Lead sponsor
Shirley Ryan AbilityLab
NCT number
NCT06503874

What you commit to

  • Study type: Interventional
  • Participants enrolled: 58
  • From 22 Mar 2024 to the primary completion date, 13 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving chemotherapy or radiation within last 6 months.

Other illness

  • Being hospitalized due to COVID-19 diagnosis for more than 3 days.
  • Pre-morbid neurological conditions that could potentially affect cognition, such as Parkinson's Disease, Alzheimer's Dementia, acquired brain injury.

Other

  • Severe depression.
  • Currently enrolled in cognitive training or physical exercise training.
  • Active substance abuse.

Who the study is looking for

  • Aged 18-65 years. Live in the Chicagoland area
  • A history of confirmed SARS-CoV-2 infection.
  • Subjective reports of cognitive symptoms that interfere with everyday activities, starting on or shortly after SARS-CoV-2 infection.
  • Continuation or development of Long-Covid brain fog 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no other explanation.
  • Objective attentional deficits as measured by the Conners CPT-312, and/or the Digit Span subtest (WAIS- III13).
  • Able to use a keyboard.
  • Able to understand and communicate in English.
  • Able to consent independently.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shirley Ryan AbilityLab
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.